Healthcare Due Diligence and Dealbreakers

What might cause a private equity GP to back away from a healthcare investment? Deal-breakers include problems in manufacturing, management, quality of earnings, clinical compliance, referral sources, reimbursement. The healthcare space is so perilous that due diligence has become more important than ever to understand risk.

The last in a four-part Privcap thought-leadership series features James Elrod of Vestar Capital Partners, Sherrill Neff of Quaker Partners, and Tammy Hill of RSM and includes an expert Q&A with Hill of RSM, sponsor of this series.

Register now to watch this video and access all content.

It's FREE!

Email*
Username*
Name*
First Last
Title*
Firm Name*
Firm Type*
Zip Code*
Password*
Enter Password Confirm Password
Hidden
Choose your newsletters
CHOOSE YOUR NEWSLETTERS:
- Private Equity
- Real Estate
Choose your newsletters*
I agree to the Privcap terms of use and privacy policy
- Yes
Already a subscriber? Sign In
Phone
This field is for validation purposes and should be left unchanged.

- Media Partners

Privcap Email Updates

Subscribe to receive email notifications whenever new talks are published.

Healthcare Due Diligence and Dealbreakers

Register now to watch this video and access all content.

It's FREE!

Already a subscriber? Sign In

Privcap Email Updates